Hyundai Pharmaceutical Co., Ltd. (KRX:004310)
South Korea · Delayed Price · Currency is KRW 6,150.00
-440.00 (-6.68%)
Aug 7, 2026, 3:30 PM KST
Hyundai Pharmaceutical Financials Overview
Financials in millions KRW. Fiscal year is December - November.
Millions KRW. Fiscal year is Dec - Nov.
| Fiscal Year | TTM | FY 2013 | FY 2012 | FY 2011 | FY 2010 | FY 2009 |
|---|---|---|---|---|---|---|
| Period Ending | Nov '13 Nov 30, 2013 | Nov '13 Nov 30, 2013 | Nov '12 Nov 30, 2012 | Nov '11 Nov 30, 2011 | Nov '10 Nov 30, 2010 | Nov '09 Nov 30, 2009 |
Revenue Revenue Growth | 108,135 | 108,135 | 102,253 | 114,276 | 111,860 | 122,879 |
Revenue Growth | 5.75% | 5.75% | -10.52% | 2.16% | -8.97% | 1.96% |
Gross Profit Gross Profit Growth | 40,491 | 40,491 | 39,071 | 45,684 | 45,529 | 49,182 |
Operating Income Operating Income Growth | 2,187 | 2,187 | -4,319 | 3,460 | -882.8 | 1,171 |
Net Income Net Income Growth | 1,415 | 1,415 | -4,850 | 520.1 | 2,968 | 1,671 |
Earnings Per Share EPS Growth | 60.34 | 60.34 | -207.00 | 22.00 | 124.33 | 67.93 |
EPS Growth | - | - | - | -82.31% | 83.05% | -48.07% |
Revenue by Segment
| Fiscal Year | TTM | FY 2013 | FY 2012 | FY 2011 | FY 2010 | FY 2009 |
|---|---|---|---|---|---|---|
| Period Ending | Nov '13 Nov 30, 2013 | Nov '13 Nov 30, 2013 | Nov '12 Nov 30, 2012 | Nov '11 Nov 30, 2011 | Nov '10 Nov 30, 2010 | Nov '09 Nov 30, 2009 |
Medical Supply Medical Supply Growth | 90,122 | 90,122 | 84,687 | 98,120 | 96,474 | 103,218 |
Food Food Growth | 18,014 | 18,014 | 17,566 | 16,156 | 15,387 | 19,661 |
Total Total Growth | 108,135 | 108,135 | 102,253 | 114,276 | 111,860 | 122,879 |
| Fiscal Year | Current | FY 2013 | FY 2012 | FY 2011 | FY 2010 | FY 2009 |
|---|---|---|---|---|---|---|
| Period Ending | Nov '13 Nov 30, 2013 | Nov '13 Nov 30, 2013 | Nov '12 Nov 30, 2012 | Nov '11 Nov 30, 2011 | Nov '10 Nov 30, 2010 | Nov '09 Nov 30, 2009 |
Cash & Investments Cash & Investments Growth | 14,630 | 14,630 | 16,610 | 13,972 | 11,320 | 7,651 |
Total Debt Total Debt Growth | 20,750 | 20,750 | 29,286 | 27,819 | 22,000 | 23,522 |
Net Cash (Debt) Net Cash Growth | -6,120 | -6,120 | -12,676 | -13,847 | -10,680 | -15,871 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -260.97 | -260.97 | -541.03 | -585.72 | -447.41 | -645.31 |
| Fiscal Year | TTM | FY 2013 | FY 2012 | FY 2011 | FY 2010 | FY 2009 |
|---|---|---|---|---|---|---|
| Period Ending | Nov '13 Nov 30, 2013 | Nov '13 Nov 30, 2013 | Nov '12 Nov 30, 2012 | Nov '11 Nov 30, 2011 | Nov '10 Nov 30, 2010 | Nov '09 Nov 30, 2009 |
Operating Cash Flow Operating Cash Flow Growth | 7,951 | 7,951 | -2,697 | 6,268 | 2,678 | -6,889 |
Capital Expenditures CapEx Growth | -2,241 | -2,241 | -1,457 | -3,682 | -3,946 | -2,327 |
Free Cash Flow Free Cash Flow Growth | 5,710 | 5,710 | -4,154 | 2,586 | -1,267 | -9,216 |
Free Cash Flow Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2013 | FY 2012 | FY 2011 | FY 2010 | FY 2009 |
|---|---|---|---|---|---|---|
| Period Ending | Nov '13 Nov 30, 2013 | Nov '13 Nov 30, 2013 | Nov '12 Nov 30, 2012 | Nov '11 Nov 30, 2011 | Nov '10 Nov 30, 2010 | Nov '09 Nov 30, 2009 |
Gross Margin | 37.45% | 37.45% | 38.21% | 39.98% | 40.70% | 40.02% |
Operating Margin | 2.02% | 2.02% | -4.22% | 3.03% | -0.79% | 0.95% |
Pretax Margin | 1.06% | 1.06% | -6.08% | 1.57% | 3.39% | 1.56% |
Profit Margin | 1.31% | 1.31% | -4.74% | 0.46% | 2.65% | 1.36% |
FCF Margin | 5.28% | 5.28% | -4.06% | 2.26% | -1.13% | -7.50% |
| Fiscal Year | Current | FY 2013 | FY 2012 | FY 2011 | FY 2010 | FY 2009 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 10, 2026 | Nov '13 Nov 30, 2013 | Nov '12 Nov 30, 2012 | Nov '11 Nov 30, 2011 | Nov '10 Nov 30, 2010 | Nov '09 Nov 30, 2009 |
Dividend Per Share Dividend Per Share Growth | 30.000 | - | - | - | 45.000 | 50.000 |
Dividend Per Share Growth | 0% | - | - | - | -10.00% | -23.08% |
Dividend Yield | 0.49% | - | - | - | 3.41% | 2.80% |
| Fiscal Year | Current | FY 2013 | FY 2012 | FY 2011 | FY 2010 | FY 2009 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 10, 2026 | Nov '13 Nov 30, 2013 | Nov '12 Nov 30, 2012 | Nov '11 Nov 30, 2011 | Nov '10 Nov 30, 2010 | Nov '09 Nov 30, 2009 |
PE Ratio | 101.93 | 30.00 | - | 53.65 | 12.92 | 33.50 |
P/FCF Ratio | 29.81 | 7.43 | - | 10.79 | - | - |
PS Ratio | 1.57 | 0.39 | 0.35 | 0.24 | 0.34 | 0.46 |